Graham Radford-Smith is the Head of IBD and TPN services, Royal Brisbane and Womens Hospital and an Honorary Group Leader, Immunology Division, Queensland Institute of Medical Research. Graham has secured over $1.8 million in NHMRC grant support as CI since 2008. He is the Editor for Genetics, IBD journal (2006-) and Past-President of theGE Society of Queensland. Graham sits on the GESA IBD Executive and GESA Research Committee and is afounding member of the International IBD Genetics Consortium. Graham was a Visiting Professor, Yale Medical School in 2009.
Graham has developed one of the largest bio-resources in this field, linking a major IBD centre with a world-class research facility. He has published extensively on clinical and scientific aspects of IBD, focusing recently on the genetic architecture of these disorders and how genes contribute to disease phenotype. Graham and his team have recently developed the first major IBD Telehealth service in Australia (2011-), linking the Royal Brisbane to regional centres in Bundaberg and Rockhampton.
Simon Travis is Professor of Clinical Gastroenterology and Fellow of Linacre College at the University of Oxford. He was President of the European Crohn’s and Colitis Organisation (ECCO, 2012-2014) and is the senior author of many peer-reviewed international guidelines.
He qualified from St Thomas’ Hospital London in 1981 and trained in Gastroenterology both in London and in Oxford, where he did his PhD on colonic epithelial electrophysiology. He was formerly Chair of the IBD Section of the BSG (2002-5), Member of Council of the British Society of Gastroenterology (2004-2007) and Chair of the scientific committee of ECCO (2007-2010). He is on the Editorial Board of Gut and Journal of Crohn’s & Colitis, among other journals.
Research interests focus on inflammatory bowel disease, clinical prediction, endoscopy and outcomes in clinical trials. He is the author of 6 books, 30 chapters and over 200 papers.
Alissa Walsh is a Consultant Gastroenterologist at St Vincent’s Hospital in Sydney where she is the Director of the Inflammatory Bowel Disease Service.
Alissa is currently on sabbatical at Oxford University, United Kingdom where she is completing her DPhil on ulcerative colitis. Alissa is the lead author of “Case Histories in Gastroenterology and Hepatology” published by the Oxford University Press, has many journal publications, is reviewer for a number of medical journals, speaks regularly at medical conferences and has several current and ongoing research projects.
Andre Wierzbicki has over 15 years of international experience in corporate finance, corporate advisory, banking and law. He commenced his career as a corporate lawyer at Allens Arthur Robinson and subsequently at the Sydney firm of Gilbert + Tobin.
Andre joined Allco Finance Group in 2004 and worked in a variety of roles and business units including aviation, wind energy and the international expension of the Allco business in Asia. From 2007 Andre was based in London with responsibility for infrastructure transactions in the UK and Europe. From 2009-2011 Andre was Founder and Executive Director of Burford Infrastructure Partners, a Sydney based advisory business with a focus on infrastructure assets. Andre is currently based in Oxford and is involved with a number of start-up ventures in the UK. Since 2014, at the invitation of the board, Andre has been Acting CEO of CCC, and is responsible for the day-to-day operation and management.
Richard Gearry is a Consultant Gastroenterologist at Christchurch Hospital and Professor of Medicine at the University of Otago, Christchurch in New Zealand. Richard has undergraduate degrees in Medicine (1995) and a PhD (2006) from the University of Otago and has completed Fellowships at Box Hill Hospital in Melbourne and St Mark’s Hospital in London.
Richard has published widely in the field of luminal gastroenterology, particularly inflammatory bowel disease, is on the Editorial Board and Grant review boards of regional and international journals and funding bodies. He is a Medical Advisor to Crohn’s and Colitis NZ, Medical Director of the New Zealand Nutrition Foundation and a Trustee of the Bowel and Liver Trust and the Christchurch Gastroenterology Research Trust.
Jane Andrews is a Senior Consultant Gastroenterologist and Head of the IBD Service at the Royal Adelaide Hospital in SA. Jane graduated from Sydney University in 1987, with postgraduate training at Royal North Shore & Concord Hospitals (Sydney) before a year at the John Radcliffe Hospital in Oxford, UK. She has a PhD from the University of Adelaide as an NHMRC Postgraduate Scholar. She is the immediate past chair of the Australian IBD Association (2011-2015) and member of the Gastroenterological Society of Australia’s Council (2011-2015).
She pioneered a new model of IBD care at the RAH, which lead to her being awarded an SA Health Award in 2012 and was instrumental in having the role of IBD nurses recognised in Australia. She is on the IBD Quality of Care Steering Committee of the Crohn’s & Colitis Association of Australia and assisting with the inaugural national audit of IBD care.
Jane has published >100 original medical papers, several letters, editorials, commentaries and book chapters. She is on the Editorial Board of three international Gastroenterology journals and is a regular reviewer for a number of journals. She is a regular invited speaker at national and international meetings and serves on many Advisory Boards, in addition to having lead many steering committees for educational meetings and seminars. She currently personally oversees ~$1M of competitive research funding and supervises projects as diverse as Faecal Transplantation, psychological care in IBD and a new model of care for functional GI disease. She is a National Examining Panel member for the RACP and a supervisor of Advanced Training in Gastroenterology. She has also been involved in submissions to regulatory bodies (PBAC & MSAC) for funding of therapies and clinical tools to optimise IBD management.
Ian Lawrance is a fulltime Gastroenterologist, a Professor in the School of Medicine and Pharmacology, Faulty of Medicine and Dentistry at the University of Western Australia and an expert in the management of IBD patients.
He has published numerous papers investigating the classification, therapeutics and fibrotic complications of the Inflammatory Bowel Diseases (IBD). He is an expert on the basic sciences of intestinal fibrosis and was invited to join the Euoropean Crohn’s and Colitis Organisation (ECCO) working group into intestinal fibrosis. He has been principle investigator on >50 international clinical trials into novel IBD medications and lead investigator on 3. He has served on international publication committees. He has 80 peer-reviewed papers in the field of IBD including Nature, Nature genetics, Lancet, NEJM and Gastroenterology papers. He is on the editorial board of numerous scientific publications and the Genetics Section Editor for Inflammatory Bowel Diseases.
In 2000 he developed the Centre for Inflammatory Bowel Diseases at Fremantle hospital and was its director since 2008. In 2015, he created a Centre for IBD at Saint John of God Hospital, Subicao and is currently its head. He is a member of the Western Australian Drug Evaluation Panel since 2005, a member of the Australian and New Zealand IBD consortium, a board member of the Australian IBD Association and co-chair of the IBD Genetics Consortium. He was head of the Department of Gastroenterology and Hepatolology at Fremantle Hospital from 2004-7, Director of Endoscopic services at Kaleeya Hospital from 2004-7 and currently sits on the numerous pharmaceutical IBD drug advisory committees
Martin Thorpe is a Division Director in the Risk Management Group at Macquarie Group Limited where he has responsibility for asset finance compliance globally and also leads a team of regulatory lawyers in Australia.
Martin has an undergraduate degree in Greek and Ancient History from the University of Nottingham in the United Kingdom and a post graduate Diploma in Law from the College of Law in London.
Martin qualified as a solicitor which Eversheds in the United Kingdom in 1998 and moved to Sydney in 2001 to join Sydney law firm Gilbert + Tobin where he practised in the firm’s corporate department for 6 years with a focus on public company mergers and acquisitions.
Martin joined Macquarie as a regulatory lawyer in 2007 and has subsequently focussed on analysing regulatory impacts of change proposals as well as establishing a compliance programme for Macquarie’s asset finance business.